These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19066200)
41. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151 [TBL] [Abstract][Full Text] [Related]
42. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. Tsantes AE; Nikolopoulos GK; Bagos PG; Rapti E; Mantzios G; Kapsimali V; Travlou A Thromb Haemost; 2007 Jun; 97(6):907-13. PubMed ID: 17549286 [TBL] [Abstract][Full Text] [Related]
43. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with genetic susceptibility to polycystic ovary syndrome: A PRISMA-compliant meta-analysis. Zhu X; Hong X; Chen L; Xuan Y; Huang K; Wang B Gene; 2019 Nov; 719():144079. PubMed ID: 31454542 [TBL] [Abstract][Full Text] [Related]
44. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232 [TBL] [Abstract][Full Text] [Related]
45. Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-β1 and plasminogen activator inhibitor 1. Li XX; Li N; Ban CJ; Zhu M; Xiao B; Dai HP Chin Med J (Engl); 2011 Jul; 124(13):1923-7. PubMed ID: 22088447 [TBL] [Abstract][Full Text] [Related]
46. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome. Nsrallah AA; Abd-El Fatah AH; Ahmed HS J Gene Med; 2019 Apr; 21(4):e3076. PubMed ID: 30743312 [TBL] [Abstract][Full Text] [Related]
47. Effects of MTHFR C677T polymorphism on homocysteine and vitamin D in women with polycystic ovary syndrome. Zhao J; Li X; Chen Q Gene; 2024 Aug; 919():148504. PubMed ID: 38670392 [TBL] [Abstract][Full Text] [Related]
48. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763 [TBL] [Abstract][Full Text] [Related]
49. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
50. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993 [TBL] [Abstract][Full Text] [Related]
51. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980 [TBL] [Abstract][Full Text] [Related]
52. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975 [TBL] [Abstract][Full Text] [Related]
53. 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis. Wang LH; Wang LM; Zhou N Arch Gynecol Obstet; 2015 Sep; 292(3):683-6. PubMed ID: 25731152 [TBL] [Abstract][Full Text] [Related]
54. PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the risk of acute lower extremity deep vein thrombosis. Pop TR; Vesa ŞC; Trifa AP; Crişan S; Buzoianu AD Rom J Morphol Embryol; 2014; 55(1):153-7. PubMed ID: 24715181 [TBL] [Abstract][Full Text] [Related]
55. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer. Eroglu A; Ulu A; Cam R; Akar N J BUON; 2006; 11(4):481-4. PubMed ID: 17309181 [TBL] [Abstract][Full Text] [Related]
56. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss. Jeddi-Tehrani M; Torabi R; Zarnani AH; Mohammadzadeh A; Arefi S; Zeraati H; Akhondi MM; Chamani-Tabriz L; Idali F; Emami S; Zarei S Am J Reprod Immunol; 2011 Aug; 66(2):149-56. PubMed ID: 21241403 [TBL] [Abstract][Full Text] [Related]
57. Association of Plasminogen Activator Inhibitor-1 Gene Polymorphisms and Methylene Tetrahydrofolate Reductase Polymorphisms with Spontaneous Miscarriages. Bubalo P; Buterin I; Šalek Z; Ðogić V; Zupančić-Šalek S Acta Haematol; 2017; 138(2):111-115. PubMed ID: 28858863 [TBL] [Abstract][Full Text] [Related]
58. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Pereira TV; Rudnicki M; Pereira AC; Pombo-de-Oliveira MS; Franco RF Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1956-63. PubMed ID: 17035405 [TBL] [Abstract][Full Text] [Related]
60. Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population. Song X; Ge L; Wang D; Li L; Ma D; Li X; Song X J Obstet Gynaecol; 2022 Oct; 42(7):3304-3308. PubMed ID: 36065507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]